Stock Scorecard



Stock Summary for Generation Bio Company (GBIO) - $4.07 as of 3/28/2024 9:33:40 PM EST

Total Score

10 out of 29

Currently on the following lists
None
Tim's Recommendation
Avoid

Growth List Algorithm Criteria for GBIO

Positive earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for GBIO

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for GBIO

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2

Bonus Criteria for GBIO

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Latest News for for GBIO

Third Harmonic Bio Appoints Geoff McDonough, M.D., to its Board of Directors 3/28/2024 12:30:00 PM
Gene therapy market size to grow by USD 4.61 billion from 2022 to 2027, North America is estimated to contribute 39 ... - PR Newswire 3/18/2024 9:36:00 AM
Generation Bio Co. ( GBIO ) Reports Q4 Loss, Lags Revenue Estimates 3/6/2024 10:40:00 PM
Generation Bio Reports Business Highlights and Fourth Quarter and Full Year 2023 Financial Results 3/6/2024 9:20:00 PM
Generation Bio to Present at the 2024 TD Cowen Health Care Conference - Generation Bio ( NASDAQ:GBIO ) 2/27/2024 11:59:00 AM
Generation Bio to Present at the 2024 TD Cowen Health Care Conference 2/27/2024 11:59:00 AM
3 Penny Stocks To Buy According To Insiders In December 12/7/2023 8:36:00 PM
Gene therapy market size to grow by USD 4,613.9 million from 2022 to 2027 | Growing research in gene therapy for ... - PR Newswire 12/1/2023 7:35:00 AM
Generation Bio Announces Strategic Reorganization to Extend Cash Runway for Development of ctLNP and iqDNA Platforms 11/29/2023 11:59:00 AM
Why Direct Digital Shares Are Trading Higher By Around 33%; Here Are 20 Stocks Moving Premarket - Aurora Cannabis ( NASDAQ:ACB ) , Aptevo Therapeutics ( NASDAQ:APVO ) 11/10/2023 1:08:00 PM

Financial Details for GBIO

Company Overview

Ticker GBIO
Company Name Generation Bio Company
Country USA
Description Generation Bio Co., a genetic drug company, develops gene therapies for the treatment of rare and prevalent diseases. The company is headquartered in Cambridge, Massachusetts.
Sector Name LIFE SCIENCES
Industry Name PHARMACEUTICAL PREPARATIONS
Most Recent Quarter 12/31/2023
Next Earnings Date 5/8/2024

Stock Price History

Last Day Price 4.07
Last Day Price Updated 3/28/2024 9:33:40 PM EST
Last Day Volume 441,898
Average Daily Volume 249,976
52-Week High 6.98
52-Week Low 0.86
Last Price to 52 Week Low 373.26%

Valuation Measures

Trailing PE N/A
Industry PE 100.07
Sector PE 60.76
5-Year Average PE -3.62
Free Cash Flow Ratio 1.02
Industry Free Cash Flow Ratio 12.70
Sector Free Cash Flow Ratio 31.04
Current Ratio Most Recent Quarter 6.83
Total Cash Per Share 3.98
Book Value Per Share Most Recent Quarter 3.07
Price to Book Ratio 1.21
Industry Price to Book Ratio 5.57
Sector Price to Book Ratio 21.66
Price to Sales Ratio Twelve Trailing Months 46.05
Industry Price to Sales Ratio Twelve Trailing Months 13.94
Sector Price to Sales Ratio Twelve Trailing Months 8.77

Share Statistics

Total Shares Outstanding 66,477,000
Market Capitalization 270,561,390
Institutional Ownership N/A

Dividends

Ex-Dividend Date N/A
Last Dividend Amount 0.00
Current Dividend Amount 0.00
Dividend Aristocrat? False
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 0.00%
Forward Annual Dividend Rate 0.00
Forward Annual Dividend Yield 0.00%
5-Year Dividend Payments Count 0
3-Year Average Dividend Yield 0.00%
5-Year Average Dividend Yield 0.00%
1-Year Dividend Growth Rate Percentage 0.00%
3-Year Dividend Growth Rate Percentage 0.00%
5-Year Dividend Growth Rate Percentage 0.00%
All-Time Dividend Growth Rate Percentage 0.00%
Dividend Payout Ratio N/A

Income Statement

Quarterly Earnings Growth YOY 0.00%
Annual Earnings Growth 7.34%
Reported EPS 12 Trailing Months -1.96
Reported EPS Past Year -1.96
Reported EPS Prior Year -2.35
Net Income Twelve Trailing Months -126,612,000
Net Income Past Year -126,612,000
Net Income Prior Year -136,639,000
Quarterly Revenue Growth YOY 0.00%
5-Year Revenue Growth 0.00%

Balance Sheet

Total Cash Most Recent Quarter 264,364,000
Total Cash Past Year 264,364,000
Total Cash Prior Year 279,091,000
Net Cash Position Most Recent Quarter 264,364,000
Net Cash Position Past Year 264,364,000
Long Term Debt Past Year 0
Long Term Debt Prior Year 0
Total Debt Most Recent Quarter 0
Equity to Debt Ratio Past Year 1.00
Equity to Debt Ratio Most Recent Quarter 1.00
Total Stockholder Equity Past Year 203,128,000
Total Stockholder Equity Prior Year 282,493,000
Total Stockholder Equity Most Recent Quarter 203,128,000

Options

Put/Call Ratio 0.00
Has Options Options Chain
Liquidity Rating

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD 0.27
MACD Signal 0.27
20-Day Bollinger Lower Band 0.78
20-Day Bollinger Middle Band 2.11
20-Day Bollinger Upper Band 3.44
Beta 2.70
RSI 64.84
50-Day SMA 3.33
200-Day SMA 0.00

System

Modified 3/28/2024 8:09:19 PM EST